• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Aegerion Pharmaceuticals Inc

+ Add to Watchlist

AEGR:US

43.4300 USD 0.0900 0.21%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Aegerion Pharmaceuticals Inc (AEGR)

Open: 42.3700 Day's Range: 42.3700 - 44.9000 Volume: 656,100
Previous Close: 43.5200 52wk Range: 37.2600 - 101.0000 1-Yr Rtn: +8.55%

Stock Chart for AEGR

No chart data available.
  • AEGR:US 43.4300
  • 1D
  • 1M
  • 1Y
43.5200
Interactive AEGR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AEGR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.2030
Est. EPS (USD) (12/2014) -0.1150
Est. PEG Ratio -
Market Cap (M USD) 1,277.32
Shares Outstanding (M) 29.41
30 Day Average Volume 1,239,709
Price/Book (mrq) 11.2901
Price/Sale (ttm) 26.0568
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AEGR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AEGR

Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches small-molecule therapeutics for cardiovascular and metabolic disease. Aegerion's product candidates limit secretion of cholesterol and triglycerides.

Marc D BeerChairman/CEOMark J FitzpatrickChief Financial Officer
Mark SumerayChief Medical OfficerMartha J CarterChief Regulatory Officer
More Company Profile & Key Executives for AEGR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil